Results 301 to 310 of about 789,387 (385)
Triple‐negative breast cancer (TNBC) remains a major challenge in breast cancer management as it lacks effective therapeutic targets. This study uncovers that MYC/TET3‐regulated mitochondrial inner‐membrane protein TMEM65 promotes TNBC progression and cisplatin resistance by activating the OXPHOS‐SERPINB3 pathway and reveals TMEM65 as a potential ...
Yin‐Ling Zhang+10 more
wiley +1 more source
Perceptions and Attitudes Toward Utilizing a Non-Invasive Biomarker for Colorectal Cancer Screening: A Qualitative Study. [PDF]
Chu CY+10 more
europepmc +1 more source
Histone lysine crotonylation (Kcr) is a highly conserved posttranslational modification implicated with crucial biological processes. This study reveals that ACSS2‐mediated H4K12cr upregulated CLDN7 transcription to strengthen intestinal epithelial barrier.
Ming Yuan+14 more
wiley +1 more source
Assessing colorectal cancer screening and outcomes among First Nations people in Alberta. [PDF]
Klassen D+7 more
europepmc +1 more source
High QSOX2 enhances stemness, drug resistance, and metastasis of ESCC cells. QSOX2‐mediated disulfide bond modification activates mTOR/c‐Myc signaling. CAFs‐secreted IGF‐1 drives mTOR/c‐Myc/QSOX2 positive feedback loop. Combining Ebselen, rapamycin, and cisplatin induces tumor dormancy in mice.
Wo‐Ming Chen+12 more
wiley +1 more source
Empowering Men to Take Control of Their Own Health: Development and Validation of the Men's Response to Colorectal Cancer Screening Scale (MR-CCSS). [PDF]
Jašić V, Prosen M, Ličen S.
europepmc +1 more source
In pancreatic ductal adenocarcinoma (PDAC), tumor‐intrinsic PD‐1 signaling activates the MET pathway, leading to the establishment of an immunosuppressive tumor microenvironment (TME). This MET‐driven signaling cascade promotes the selective accumulation of GITR+ regulatory T cells (Tregs), a highly immunosuppressive subset.
Jiande Han+16 more
wiley +1 more source
Evaluating the implementation of colorectal cancer screening practices at King Abdul-Aziz Medical City, Riyadh. [PDF]
Al Turki MS+3 more
europepmc +1 more source
Advanced Microfluidics for Single Cell‐Based Cancer Research
Cutting‐edge microfluidic platforms are transforming single‐cell cancer research. This review highlights advanced technologies, from droplet microfluidics to tumour‐chips, that enable functional and spatial single‐cell analyses. By integrating biosensing, immune components, and patient‐derived materials, these systems offer new insights into tumour ...
Adriana Carneiro+10 more
wiley +1 more source